Inactive Instrument

News Össur hf. Other OTC

Equities

Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024	23/04
Embla Medical hf: Interim Report Q1 2024	23/04	AQ
Embla Medical hf. Provides Earnings Guidance for the Year 2024	23/04	CI
Embla Medical hf. Reports Earnings Results for the First Quarter Ended March 31, 2024	23/04	CI
Össur hf. will Change its Name to Embla Medical hf	08/04	CI
Össur hf: Board Decisions Following the Annual General Meeting	13/03	AQ
Össur hf. Appoints Caroline Vagner Rosenstand to the Audit Committee	13/03	CI
Össur hf: Results of the Annual General Meeting	13/03	AQ
Össur hf: Candidates to the Board of Directors	10/03	AQ
Össur hf: Final Agenda and Proposals for the Annual General Meeting 13 March 2024	28/02	AQ
Össur hf: Össur establishes new parent organization to be named Embla Medical	21/02	AQ
Össur hf Establishes New Parent Organization to Be Named Embla Medical	21/02	CI
Össur hf: Annual General Meeting 13 March 2024	21/02	AQ
Transcript : Össur hf., Q4 2023 Earnings Call, Jan 30, 2024	30/01
Össur hf: Annual Report 2023	30/01	AQ
Össur hf: Interim Report Q4 2023	30/01	AQ
Össur hf. Reports Earnings Results for the Full Year Ended December 31, 2023	30/01	CI
Össur hf. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	30/01	CI
Össur hf. Provides Earnings Guidance for the Year 2024	30/01	CI
Össur hf: Össur's total share capital following completion of capital increase of 6,636,122 shares	24/01	AQ

No results for this search